Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | -7.97% | -23.49% | +124.78% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Nektar Therapeutics Reiterates Earnings Guidance for the Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.78% | 23Cr | |
+39.82% | 73TCr | |
+31.34% | 59TCr | |
-7.31% | 35TCr | |
+14.23% | 32TCr | |
+0.86% | 28TCr | |
+13.47% | 24TCr | |
-6.63% | 20TCr | |
+7.49% | 21TCr | |
+4.51% | 16TCr |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Nektar Therapeutics Plunges After Joint Trials With Bristol-Myers Squibb Stopped for Cancer Combination Therapy